T. van der Laan - Concepedia

Author

T. van der Laan

Radboud University Nijmegen

Also Known As

T van der Laan, T. Van Der Laan, T. van der Laan, Tineke van der Laan

Publications

341

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center National Institute for Public Health and the Environment University Medical Center Groningen Wageningen University & Research

About

T. van der Laan is an author at Radboud University Nijmegen specializing in medicine, tuberculosis, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	116
2	Health Sciences	2	2	78
3	Engineering	1	1	38
4	Environmental Engineering	1	1	38
5	Medical Laboratory Science	1	1	13

T. van der Laan

Publications

324

Citations

H-Index

Page 1

	Year	Citations
Use of IS901 and IS1245 in RFLP typing of Mycobacterium avium complex: relatedness among serovar reference strains, human and animal isolates. Viviana Ritacco, Kristin Kremer, T. van der Laan, PubMed	1998	107
Susceptibility of Clinical <i>Mycobacterium tuberculosis</i> Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480 Jan‐Willem C. Alffenaar, T. van der Laan, Sami O. Simons, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceMedical Microbiology	2011	65
Survey of Campylobacter spp. in sewage plants in The Netherlands P.M.F.J. Koenraad, W.C. Hazeleger, T. van der Laan, Food Microbiology EngineeringEnvironmental EngineeringMunicipal WastewaterMicrobial EcologyCampylobacter Infections	1994	38
Antibiotic susceptibility of campylobacter isolates from sewage and poultry abattoir drain water P.M.F.J. Koenraad, W.F. Jacobs‐Reitsma, T. van der Laan, Epidemiology and Infection	1995	29
<i>In Vitro</i> Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin Jacob A. Dijkstra, T. van der Laan, Onno W. Akkerman, Antimicrobial Agents and Chemotherapy	2018	28
Second-line drug resistance in multidrug-resistant tuberculosis cases of various origins in the Netherlands. Jakko van Ingen, Martin J. Boeree, A Wright, PubMed	2008	16
Molecular drug susceptibility testing in the Netherlands: performance of the MTBDR<I>plus</I> and MTBDR<I>sl</I> assays Sami O. Simons, T. van der Laan, Rina de Zwaan, The International Journal of Tuberculosis and Lung Disease	2015	15
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania Jossy van den Boogaard, Hadija Semvua, Jakko van Ingen, Journal of Antimicrobial Chemotherapy	2011	13
Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm Sami O. Simons, T. van der Laan, A. Mulder, Clinical Microbiology and Infection DiagnosisDiagnosticsDrug ResistanceMolecular-based Diagnostic AlgorithmBioanalysis	2014	13

Page 1